AutoGenomics, Inc.

Test & Measurement

AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay

CARLSBAD, Calif., Jan. 24 - AutoGenomics, a leader in developing automated molecular testing solutions announced today that it has obtained clearance from the Food and Drug Administration (FDA) for its INFINITI 2C9-VKORC1 Multiplex Assay for Warfarin. The company has already received FDA clearance for its INFINITI Analyzer and FII/FV assays in 2007. We are excited to receive FDA clearance for our...

Read More »
Company News

AutoGenomics to Present at Cowen Health Care Conference on March 17, 2008

CARLSBAD, Calif., March 10 - AutoGenomics, a leader in developing automated molecular testing solutions, announced today that it will be among the leading healthcare and biotechnology companies presenting at the 28th Annual Cowen Health Care Conference that will be held at the Boston Marriott Copley Place in Boston, Massachusetts. Fareed Kureshy, President and Chief Executive Officer will present...

Read More »
Test & Measurement

AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay

CARLSBAD, Calif., Jan. 24 - AutoGenomics, a leader in developing automated molecular testing solutions announced today that it has obtained clearance from the Food and Drug Administration (FDA) for its INFINITI 2C9-VKORC1 Multiplex Assay for Warfarin. The company has already received FDA clearance for its INFINITI Analyzer and FII/FV assays in 2007. We are excited to receive FDA clearance for our...

Read More »

All Topics